Professional profile
Amit Bahl is Consultant Clinical Oncologist and Head of
Radiotherapy at Bristol Haematology & Oncology Centre with a
special interest in breast and urological cancers.
He is the research lead for Bristol haematology and Oncology
Centre. He has led and developed the prostate brachytherapy service
at BHOC. He has been an expert adviser to NICE for the
technology appraisal on new drugs and an external service reviewer
at oncology departments elsewhere in the country.
Prior to his current roles, Dr Bahl became Member of the Royal
College of Physicians (UK) and trained in Clinical Oncology,
achieving the Fellowship of the Royal College of Radiologists
qualification. He has been awarded the fellowship of the Royal
College of Physicians.
He is a current member of the National Cancer Research Institute
Clinical Studies Groups for prostate, bladder and penile cancer,
college tutor of the Royal College of Radiologists and has also
supervised three MD research projects in breast and prostate
cancer. He has previously been in the NCRI Renal clinical studies
group.
Current NHS or research position
Consultant Clinical Oncologist and Head of Radiotherapy at
Bristol Haematology & Oncology Centre
Research interests
Dr Bahl is actively involved in research into breast, prostate
and bladder cancers, participates in clinical trials locally and
nationally and regularly publishes articles in these research
areas.
Current membership(s) of professional, national and regional bodies
National Cancer Research Institute Clinical Studies Groups for
prostate, bladder and penile cancer